Table of Contents

Table of Contents

Preface pp.vii-xii

Optimizing Ribavirin Use for the Treatment of Hepatitis C
(Melissa Palmer, NYU Langone, and Kadmon Corporation, New York, NY, USA)pp.-1-36

Ribavirin and its Great Potentials in Infectious Diseases
(Gamal Esmat, Mohamed El Kassas, Tamer Elbaz, Maissa El Raziky, Endemic Medicine and Hepatogastroenterology Department, Faculty of Medicine, Cairo University, Cairo, Egypt, and others)pp.37-58

Antiviral Actions of Ribavirin
(Inés Yeste-Gomez, Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain)pp.59-78

A Novel Prediction Method for the Responsiveness of Hepatitis C Patients to Drug Treatment
(Shigeru Takasaki, Toyo University, Izumino, Ora-gun Itakuracho, Gunma, Japan)pp.79-92

Ribavirin Intolerable Cough during HCV Combination Therapy can be Overcome by Nitazoxanide Replacement
(Mohamed H. Emara, Salem Y. Mohamed, Tropical Medicine Department, Faculty of Medicine, Zagazig University, Egypt, and others)pp93-100

Index pp.101-108